References
1. Damascena LCL, de Lucena NNN, Ribeiro ILA, Pereira TL, Lima-Filho LMA, Valença AMG. Severe Oral Mucositis in Pediatric Cancer Patients: Survival Analysis and Predictive Factors. Int J Environ Res Public Health. 2020;17:1235
2. Tomizawa D, Tawa A, Watanabe T et al. Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children. Leukemia. 2013;27:2413-6
3. Kusiak A, Jereczek-Fossa BA, Cichońska D, Alterio D. Oncological-Therapy Related Oral Mucositis as an Interdisciplinary Problem-Literature Review. Int J Environ Res Public Health. 2020;17:2464
4. Chaimberg KH, Cravero JP. Mucositis and airway obstruction in a pediatric patient. Anesth Analg. 2004;99:59-61
5. Walsh LJ. Clinical assessment and management of the oral environment in the oncology patient. Aust Dent J. 2010;55:66-77
6. Raber-Durlacher JE, Weijl NI, Abu Saris M, de Koning B, Zwinderman AH, Osanto S. Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Support Care Cancer. 2000;8:366-371
7. Drew B, Peters C, Rimell F. Upper airway complications in children after bone marrow transplantation. Laryngoscope. 2000;110:1446-1451.
8. McCann S, Schwenkglenks M, Bacon P, et al. The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. Bone Marrow Transplant. 2009;43:141-147
9. Blijlevens NMA, Logan RM, Netea MG. Mucositis: from febrile neutropenia to febrile mucositis. Journal of Antimicrobial Chemotherapy, 2009;63:i36-i40
10. Blijlevens NM, Donnelly JP, de Pauw BE. Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy. Clin Microbiol Infect. 2001;7:47-52
11. van der Velden WJ, Herbers AH, Netea MG, Blijlevens NM. Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol. 2014;167:441-452
12. Raber-Durlacher JE, von Bültzingslöwen I, Logan RM, et al. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21:343-355
13. Manna SS, Malik R, Douthwaite A, Vaidya S. Surgical tracheostomy in children with malignancy receiving intensive chemotherapy: A case series and review of literature. Pediatr Blood Cancer. 2020;67:e28105
14. Raimondi N, Vial MR, Calleja J, et al. Evidence-based guidelines for the use of tracheostomy in critically ill patients. J Crit Care. 2017;38:304-318
15. Blot F, Nitenberg G, Guiguet M, et al. Safety of tracheotomy in neutropenic patients: a retrospective study of 26 consecutive cases. Intensive Care Med. 1995;21:687-690